Table 2.
Item No | TNF-α | IL-6 | INF-γ | Dexa | COX2 | iNOS | Item No | TNF-α | IL-6 | INF-γ | Dexa | COX2 | iNOS |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
55 | — | — | — | — | — | ↓ | 79 | — | — | ↑ | ↑ | — | — |
56 | — | — | — | — | — | — | 80 | — | — | — | — | — | — |
57 | — | — | — | — | — | — | 81 | — | — | — | — | — | — |
58 | — | — | — | — | — | — | 82 | — | ↑ | ↑ | — | — | ↓ |
59 | — | — | — | — | — | — | 83 | — | — | ↑ | — | — | — |
60 | — | ↑ | — | — | — | — | 84 | — | — | — | — | — | — |
61 | — | — | — | — | — | ↓ | 85 | — | — | — | — | — | — |
62 | — | — | — | — | — | ↓ | 86 | — | — | — | — | — | ↓ |
63 | — | — | — | — | — | — | 87 | — | — | — | — | — | — |
64 | — | — | — | — | ↓ | — | 88 | — | — | — | — | — | — |
65 | — | — | — | — | ↓ | ↓ | 89 | — | — | — | — | — | ↓ |
66 | — | ↑ | — | — | — | ↓ | 90 | — | — | — | — | ↓ | — |
67 | — | — | — | — | — | ↓ | 91 | — | — | — | — | — | ↓ |
68 | — | — | — | — | — | — | 92 | — | — | — | — | — | — |
69 | — | — | — | ↓ | — | ↓ | 93 | — | — | — | — | — | ↓ |
70 | — | — | — | — | ↓ | — | 94 | — | — | — | — | — | — |
71 | — | — | — | — | — | — | 95 | — | ↑ | ↓ | — | — | — |
72 | — | — | — | — | — | — | 96 | — | ↑ | — | ↓ | — | ↓ |
73 | — | — | — | — | — | ↓ | 97 | — | ↑ | — | — | — | — |
74 | — | — | — | — | — | ↓ | 98 | — | — | — | — | ↓ | — |
75 | — | — | — | — | — | — | 99 | — | ↑ | — | ↑ | — | — |
76 | — | — | — | — | — | — | 100 | — | — | — | — | — | — |
77 | — | — | — | — | — | — | 101 | — | — | — | — | — | — |
78 | — | — | — | — | ↓ | ↓ |
TNF-α: TNFα-NFκB luciferase reporter; IL-6: IL-6-STAT3 luciferase reporter; INF-γ: INFγ-GAS luciferase reporter; Dexa: Dexamethasone-GRE luciferase reporter; COX2: COX2 enzyme activity; iNOS: iNOS enzyme activity. ↓: inhibition ≥ 50%; ↑: stimulation ≥ 3 folds; —: no impact w/o β-glucuronidase treatment at concentration ≤ 750 µg/ml in the inflammatory cytokine or glucocorticoid signaling pathway and at concentration ≤ 4 mg/ml in COX2, iNOS enzyme activity assay.